Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dominique Hétuin
Observed names:
D Hetuin,
D Hétuin,
Dominique Hetuin
Institutions:
Inserm,
Institut pour la Recherche sur le Cancer de Lille
Observed institutions:
Inserm,
Université de Lille,
Centre Hospitalier Universitaire de Lille,
Institut pour la Recherche sur le Cancer de Lille,
Université Paris Diderot,
Université Lille Nord de France
show all 6
OpenAlex ID:
A5043699093
Mis-splicing yields circular RNA molecules.
1993
·
C Cocquerelle
, B Mascrez
, et al.
·
The FASEB Journal
·
1,189
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
2007
·
Jizhong Liu
, Abdelbasset Hamrouni
, et al.
·
Blood
·
597
PDF
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
2010
·
Céline Berthon
, Virginie Driss
, et al.
·
Cancer Immunology Immunotherapy
·
175
PDF
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
2014
·
A-L Nugues
, H El Bouazzati
, et al.
·
Cell Death and Disease
·
140
PDF
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells
2004
·
Aurore Saudemont
, Nathalie Jouy
, et al.
·
Blood
·
138
PDF
γ‐Ray irradiation induces B7.1 expression in myeloid leukaemic cells
2000
·
Rodolphe Vereecque
, Geraldine Buffenoir
, et al.
·
British Journal of Haematology
·
61
PDF
GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells
2011
·
S Joha
, A-L Nugues
, et al.
·
Oncogene
·
56
PDF
Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2007
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
·
Cancer Research
·
54
BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism
2008
·
J Liu
, S Joha
, et al.
·
Leukemia
·
49
Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia
2002
·
A Saudemont
, G Buffenoir
, et al.
·
Leukemia
·
48
Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease
2000
·
R Vereecque
, G Buffenoir
, et al.
·
Gene Therapy
·
43
Transduction of Bone Marrow Cells by the AdZ.F(pK7) Modified Adenovirus Demonstrates Preferential Gene Transfer in Myeloma Cells
1999
·
Ricardo Gonzalez
, Rodolphe Vereecque
, et al.
·
Human Gene Therapy
·
41
A Structural Explanation of the Effects of Dissociated Glucocorticoids on Glucocorticoid Receptor Transactivation
2013
·
Xavier Dezitter
, Jérôme Fagart
, et al.
·
Molecular Pharmacology
·
23
Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation
1996
·
Bruno Quesnel
, Claude Preudhomme
, et al.
·
British Journal of Haematology
·
23
γ-Irradiation enhances transgene expression in leukemic cells
2003
·
R Vereecque
, A Saudemont
, et al.
·
Gene Therapy
·
19
Induction of leukemia-specific CD8+ cytotoxic t cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-α
2005
·
Aurore Saudemont
, Selim Corm
, et al.
·
Molecular Therapy
·
10
PDF
Supplementary Table 1 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
Supplementary Figure 4 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
Supplementary Figure 1 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
Supplementary Figure 6 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
PDF
Supplementary Figure 2 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
PDF
Supplementary Figure 5 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
Supplementary Figure 4 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
PDF
Supplementary Figure 5 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
PDF
Supplementary Figure 1 from Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
2023
·
Aurore Saudemont
, Abdelbasset Hamrouni
, et al.
PDF
Show more works
View as search
Works count:
29
Citation count:
2,666
H-index:
15
I10-index:
16
Year
Topic
Type